[DOI] [PubMed] [Google Scholar] 42.LeCluyse E., Appel L.E., Sutton S.C
Why niacinamide is added to Empower tirzepatide The niacinamide question comes up constantly
- when there is risk of torsades de pointes, for example in patients with prolonged QT, concomitant administration of other medications that produce torsades de pointes (amiodarone, quinidine, bepridil, IV erythromycin, halofrantine, pentamidine, sparfloxacin, sultopride, vincamine, betrilio, disopyramide, sotalol, etc)
According to the National Institutes of Health (NIH- department of the HHS), there is concern for acute pancreatitis and long-term consequences on the thyroid gland with usage of the GLP-1 RA medication
If determined medically appropriate by one of our partner clinicians, a compounded GLP-1 may be prescribed
This could grow the litigation by several thousand cases overnight